Setting care priorities for older women after breast cancer treatment
Official title: Patient Priorities for Survivorship Care in Older Breast Cancer Survivors
Run by The University of Texas Health Science Center, Houston · NCT06478589 · Data updated 2026-11-12
This project will test a patient‑priorities approach to see if it helps older women who finished breast cancer treatment get survivorship care that matches their goals.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 65 Years to 100 Years |
| Sex | Women only |
| Enrollment | 120 (estimated) |
| Sponsor | The University of Texas Health Science Center, Houston Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 3 sites (Bellaire, Texas and 2 other locations) |
| Status | Recruiting |
| Started | January 2, 2025 |
| Main results expected | December 1, 2026 |
| Study ends | June 1, 2027 |
| Registry record updated | August 12, 2025 |
| Trial ID | NCT06478589 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are English-speaking older women with stage DCIS–III breast cancer who are 3 months to 10 years post‑treatment and have multiple chronic conditions, high medication use, recent hospitalizations or ED visits, or multiple specialty visits.
✕Probably not a fit
Patients currently receiving active cancer therapy, non-English speakers, survivors less than 3 months or more than 10 years from treatment, or those without multiple comorbidities are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will adapt the Patient Priorities Care (PPC) framework to the breast cancer survivorship setting using a user-centered, iterative process with input from patients, oncologists, geriatricians, and patient advocates. The adapted intervention consists of a facilitator-led health priorities identification session followed by an oncology visit to align the care plan with those priorities. After refinement by an advisory panel, participants will be randomized to the adapted PPC versus usual care in a randomized quality improvement project. Primary outcomes include feasibility, treatment burden and quality of life at 3 months, and adherence to priorities-driven survivorship recommendations at 12 months.
Why it matters
Potential benefit: If successful, the approach could help older survivors receive more personalized survivorship care, reduce treatment burden, and improve quality of life.
How similar studies have gone: PPC-style approaches have shown feasibility and promise in older adults with multimorbidity, but adapting this framework specifically for breast cancer survivorship is a novel application.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * able to write and speak English * Stage DCIS/I/II/III breast cancer diagnosis * 3 months from active cancer therapy (including first or second-line treatment chemotherapy, radiation and/or surgery, or multimodal treatment) up to 10 years since completing treatment * ≥3 documented comorbidities by chart review, or taking ≥10 medications, have ≥ 1 hospitalization over the past year, ≥ 2 emergency department visits over the past year, seen by \> 2 specialists over the past year * able to provide consent Exclusion Criteria: * currently on active cancer therapy (including first or second-line treatment chemotherapy, radiation and/or surgery, or multimodal treatment)
Where it's running
-
UT Physicians Center for Healthy Aging Bellaire
Bellaire, Texas, United States Recruiting -
UT Physicians Family Medicine Bayshore
Houston, Texas, United States Recruiting -
Memorial Hermann Cancer Center
Houston, Texas, United States Recruiting
Study contacts
- Principal investigator: Dana E. Giza, MD — The University of Texas Health Science Center, Houston
- Study coordinator: Dana E. Giza, MD
- Email: Dana.E.Giza@uth.tmc.edu
- Phone: (713) 500-6087
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Weight management program for breast cancer survivors in rural communities
This program will test whether a 12-week remote WeCan-Rural program helps rural breast cancer survivors with obesity lose weight, ease symptoms, and lower heart disease risk.
-
Daily broccoli microgreens for breast cancer survivors with obesity
This two-week test will see if eating one cup of fresh broccoli microgreens each day is doable and changes metabolism and gut health in obese breast cancer survivors.
-
Personalized digital healthcare for managing side effects in breast cancer survivors
This study is testing a new digital health program to help breast cancer survivors manage side effects from their treatments using a mobile app and smartwatch.
-
Need-based cancer survivorship program implementation
This project tests a need-based survivorship program for adults who have finished cancer treatment to see if targeted screenings and referrals can help manage symptoms and weight concerns.
-
Bridging psychosocial care after cancer treatment
This study tests a routine digital distress screen plus a psycho-oncology navigation call to help cancer survivors access support after completing treatment.
-
Hematologic cancer survivors after stem cell transplant try a personalized care plan
This study tests a personalized Survivorship Care Plan for people with hematologic cancer who have undergone a stem cell transplant to see if it’s feasible within the Italian health system.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.